Prescribing efficiency of proton pump inhibitors in China: influence and future directions

BACKGROUND: Pharmaceutical expenditure is currently rising by 16% per annum in China, greater in recent years. Initiatives to moderate growth include drug pricing regulations, essential medicine lists and encouraging generic prescribing. These are principally concentrated in hospitals, which current...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Wenjie, Finlayson, Alexander E, Shankar, Sushma, de Bruyn, Winnie, Godman, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308879/
https://www.ncbi.nlm.nih.gov/pubmed/25609265
http://dx.doi.org/10.1186/s12913-014-0638-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308879/
https://www.ncbi.nlm.nih.gov/pubmed/25609265
http://dx.doi.org/10.1186/s12913-014-0638-6

Ejemplares similares